Safety and Efficacy of BIP48 (Peginterferon Alfa 2b 48kDa) Compared With Pegasys (Peginterferon 2a 40kDa) for Treatment of Chronic Hepatitis C: Randomized, Multicentric Study With Blinded Analysis
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Peginterferon alfa-2b (Primary) ; Peginterferon alfa-2a
- Indications Hepatitis C
- Focus Therapeutic Use
- 26 Jun 2012 New trial record
- 20 Jun 2012 Biomarkers information updated